Glenn Baity, VP AND GC at ACADIA PHARMACEUTICALS INC (ACAD), sold 60,000 shares at $13.00 ($745K) on 2013-04-11, disclosed to the SEC on 2013-04-12.
Scheduled sale ($745k) by VP AND GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.06 | 10,000 | $111K | 14.8% |
| 2 | $12.00 | 10,000 | $120K | 16.1% |
| 3 | $13.00 | 10,000 | $130K | 17.4% |
| 4 | $12.74 | 20,000 | $255K | 34.2% |
| 5 | $13.00 | 10,000 | $130K | 17.4% |
| Total | $12.42 avg | 60,000 |
| $745K |
| 100% |
| Filing → |
| ACAD | SELL | 2017-10-06 | $3.1M | — | Filing → |
| ACAD | SELL | 2017-09-01 | $924K | — | Filing → |
| ACAD | SELL | 2017-08-11 | $500K | — | Filing → |